A sizable patient pool has been opting for various alternative therapies for sleep management, including nonprescription drugs, prescription drugs, and sleep aid devices. Widespread availability and launch of sleep aid products to treat sleep disorders are the factors for commercial success of the sleep aids market.
In terms of revenue, others product type segment-consisting of mattresses and pillows, chin straps and mouth pieces & nasal devices is projected to remain dominant. By indication type, insomnia segment is expected to be most dominant segments and collectively gain more the 35% market share over the forecast period. Sleep apnea segment is expected to gain more traction than narcolepsy over the next decade owing to rising prevalence of obstructive sleep apnea.Among all distribution channel e commerce segment is the second most dominant segment for sleep aids market which is then followed by hospital pharmacies. Asia-Pacific is the second most lucrative region for the sleep aids market and projected to grow at fastest CAGR over the forecast period.